Twelfth Annual AACR International Conference on Frontiers in Cancer Prevention Re

第十二届 AACR 癌症预防前沿国际会议

• 批准号: 8652143
• 负责人: Margaret Foti
• 金额: $ 3万
• 依托单位: AMERICAN ASSOCIATION FOR CANCER RESEARCH
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-27 至 2014-09-26
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8652143
• 关键词: Advocate; American Association of Cancer Research; Attention; Awareness; Basic Science; Behavioral; Carcinogens; Clinical; Collaborations; Colonoscopy; Data; Disease; Early Diagnosis; Early treatment; Education; Effectiveness; Epidemiology; Event; Exercise; Exposure to; Fostering; HBV Vaccination; Health Professional; Hepatitis B Virus; Human; Human Papillomavirus; Incidence; Individual; Information Technology; International; Intervention; Learning; Lesion; Life Style; Mainstreaming; Malignant Neoplasms; Maryland; Molecular; Patients; Physicians; Polypectomy; Population; Premalignant; Prevention; Prevention Research; Prevention strategy; Primary Prevention; Process; Public Health; Recurrence; Research; Research Personnel; Research Technics; Resort; Risk; Scientific Advances and Accomplishments; Scientist; Second Primary Cancers; Secondary Prevention; Series; Specific qualifier value; Survivors; Tobacco; Tobacco use; Translating; Translations; cancer prevention; carcinogenesis; career; clinical application; frontier; interdisciplinary collaboration; interest; lectures; meetings; mortality; posters; prevent; public health relevance; screening; skills; symposium; tertiary prevention; vaccine development

DESCRIPTION (provided by applicant): The Twelfth Annual International Conference on Frontiers in Cancer Prevention Research will take place October 27-30, 2013, at the Gaylord National Resort and Conference Center in National Harbor, Maryland. The AACR has long been a supporter of cancer prevention research aimed at preventing cancer through lifestyle changes and early detection and treatment. This annual AACR conference series debuted in 2002 and remains the pre-eminent cancer prevention meeting in the world, a place where physicians, scientists, patients, and survivor advocates learn about the latest translational discoveries from the leading basic, clinical, epidemiologic, and behavioral scientists in the field. The conference fosters interdisciplinary collaborations, accelerates progression in the field of prevention research, and promotes awareness of the vital importance and of cancer prevention in reducing cancer incidence and mortality. This year's conference theme, "Accelerating Discovery, Translation, and Application," will put the spotlight on the power of prevention. Scientific advances are transforming the field of cancer prevention by providing us with the information and technology needed to understand the molecular underpinnings of carcinogenesis in humans and to identify and intervene in disease processes with unprecedented accuracy and effectiveness. By accelerating new discoveries and translating our understanding of the basic science into clinical application, benefits are being seen at the public health level. Several step within carcinogenic initiation and progression are targets for cancer prevention. Primary prevention is the avoidance of exposure to carcinogens or the carcinogenic process and may be directed at the broad population of individuals who show no sign of premalignancy. Exercise and avoidance of tobacco are examples of this type of intervention. And one of the most successful primary prevention strategies is the development of vaccines such as those for HBV and HPV. Secondary prevention efforts are receiving attention and include screening and early detection, which are generally directed toward a more specified risk population. Examples of this type of prevention include colonoscopy and polypectomy. Studies have found that premalignant lesions may be more common than previously realized and it will be crucial to understand who some premalignant lesions progress to cancer and others do not. Finally, tertiary prevention is aimed at preventing recurrence or second cancers.

描述（由申请人提供）：第十二届癌症预防研究前沿国际年会将于2013年10月27日至30日在马里兰州国家港的盖洛德国家度假村和会议中心举行。AACR长期以来一直是癌症预防研究的支持者，旨在通过改变生活方式和早期发现和治疗来预防癌症。这个年度AACR会议系列于2002年首次亮相，仍然是世界上最杰出的癌症预防会议，医生，科学家，患者和幸存者倡导者可以在这里了解该领域领先的基础，临床，流行病学和行为科学家的最新翻译发现。该会议促进跨学科合作，加速预防研究领域的进展，并提高对癌症预防在降低癌症发病率和死亡率方面的重要性的认识。今年会议的主题是“加速发现、转化和应用”，将重点关注预防的力量。科学进步正在改变癌症预防领域，为我们提供了了解人类致癌作用的分子基础所需的信息和技术，并以前所未有的准确性和有效性识别和干预疾病过程。通过加速新的发现，并将我们对基础科学的理解转化为临床应用，在公共卫生层面上看到了好处。致癌起始和进展中的几个步骤是癌症预防的目标。一级预防是避免暴露于致癌物或致癌过程，可针对未显示癌前病变迹象的广大人群。运动和避免吸烟是这种干预的例子。最成功的一级预防策略之一是开发疫苗，如HBV和HPV疫苗。二级预防工作正在受到重视，包括筛查和早期发现，这些工作通常针对更具体的风险人群。这类预防的例子包括结肠镜检查和息肉切除术。研究发现，癌前病变可能比以前认识到的更常见，了解哪些癌前病变进展为癌症，而另一些则没有进展，这将是至关重要的。最后，三级预防旨在预防复发或第二次癌症。